drugset / Trial / NCT03268902

Early Life Interventions for Childhood Growth and Development In Tanzania

NCT03268902

RandomizedFactorialQuadruple-blindTreatment

Summary

This study aims to assess growth and cognitive effects of treatment with azithromycin and nitazoxanide and/or nicotinamide (vitamin B3) supplementation nicotinamide.

Timeline

Start
2017-09-05
Primary completion
2020-02-28
Completion
2020-03-26

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 20 mg/kg Oral
Subject Nicotinamide Other / unclassified 100 mg Oral
Subject Nicotinamide Other / unclassified 250 mg Oral
Subject Nitazoxanide Other / unclassified 100 mg Oral